Cancer Immunology and Immunotherapy. Springer Science and Business Media Deutschland GmbH Rijnders, M, Robbrecht, D G J, Oostvogels, A A M, van Brakel, M, Boormans, J L, Aarts, M J B, Balcioglu, H E, Hamberg, P, Voortman, J, Westgeest, H M, Lolkema, M P, de Wit, R, van der Veldt, A A M & Debets, R 2022, ' A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancer ', Cancer Immunology and Immunotherapy . https://doi.org/10.1007/s00262-022-03250-0 Cancer Immunology Immunotherapy, 72(3), 759-767. Springer Science+Business Media Cancer Immunology Immunotherapy, 72(3), 759-767. Springer Cancer Immunology, Immunotherapy. Springer Science and Business Media Deutschland GmbH